Our Financial Support

Pursuant to our Standards of Excellence, we disclose the financial support we receive from our sponsors and post our disclosures on this webpage within six months of the close of the fiscal year.

In addition, we follow the same transparency-focused policies and procedures we ask our members to meet regarding corporate relations, transparency, and conflict of interest. Read more about our:

The companies and organizations below have provided funding for a variety of programmatic efforts including: qualitative and quantitative research; multi-stakeholder roundtables on topics ranging from patient engagement to utilizing real-world evidence; educational programs for patients and patient advocates; and several annual conferences. We gratefully acknowledge their support.

Click here to view our 2019 audited financials.

The companies and organizations below have provided funding for a variety of programmatic efforts including: qualitative and quantitative research; multi-stakeholder roundtables on topics ranging from patient engagement to utilizing real-world evidence; educational programs for patients and patient advocates; and several annual conferences. We gratefully acknowledge their support.

To learn about current sponsorship opportunities with the NHC, contact Mary Crowther, Associate, Development.

The following disclosure information includes the total amount of support received from each sponsor.

2018 Sponsors*

*Includes membership dues

In 2018, 75.6% of the NHC overall revenue came from insurance, pharmaceutical, biotechnology, and medical device companies. The specific amounts from each company or organization are listed below in U.S. dollars:

Corporate Sponsor

2018 Sponsorship

2018 Programs Sponsored**

2018 Dues Amount

Total Giving

Abbott

32,00032,000
Abbvie50,000
  • Patient-Journey Mapping
32,00082,000
Advanced Medical Technology Association12,000
  • Emerging Issues
8,00020,000
Aetna

32,00032,000
Alkermes30,000
  • Health Leadership Conference
32,00062,000
Allergan125,000
  • Patient-Journey Mapping
  • Clinical Outcome Assessment
  • Fair-Market Value Calculator
  • Value
32,000157,000
America’s Health Insurance Plans

8,0008,000
Amgen100,000
  • Payment Models/Delivery Design
  • Quality
  • Value
  • Washington Representatives Retreat
32,000132,000
Anthem

32,00032,000
Association for Accessible Medicine35,000
  • Health Leadership Conference
  • Washington Representatives Retreat
8,00043,000
Astellas Pharma, US30,000
  • Washington Representatives Retreat
  • Emerging Issues
32,00062,000
AstraZeneca Pharmaceuticals

32,00032,000
Biogen Inc25,000
  • Fair-Market Value Calculator
32,00057,000
Biotechnology Industry Organization

8,0008,000
Boehringer Ingelheim Pharmaceuticals75,000
  • Patient-Journey Mapping
  • Fair-Market Value Calculator
32,000107,000
Bristol-Myers Squibb Company100,000
  • Health Leadership Conference
  • Washington Representatives Retreat
  • Emerging Issues
32,000132,000
Celgene Corporation

32,00032,000
Dermira

32,00032,000
Edwards Lifesciences

8,0008,000
Eli Lily and Company120,000
  • Patient Engagement
  • Real-World Evidence
  • Health Leadership Conference
  • Washington Representatives Retreat
32,000152,000
Genentech57,000
  • Health Leadership Conference
  • Emerging Issues
32,00089,000
GlaxoSmithKline20,000
  • Patient Engagement
32,00052,000
Grifols

32,00032,000
Horizon Pharmaceuticals25,000
  • Value
16,00041,000
Intarcia

1,2001,200
Johnson & Johnson50,000
  • Fair-Market Value Calculator
32,00082,000
Mallinckrodt

32,00032,000
Merck & Co., Inc.265,000
  • Patient Engagement
  • Fair-Market Value Calculator
  • Health Leadership Conference
  • Washington Representatives Retreat
  • Science Symposium
  • Emerging Issues
32,000297,000
Novartis245,000
  • Patient Engagement
  • Fair-Market Value Calculator
  • Value
  • Health Leadership Conference
  • Emerging Issues
32,000277,000
Pfizer Inc310,000
  • Fair-Market Value Calculator
  • Value
  • Health Leadership Conference
  • Washington Representatives Retreat
  • Emerging Issues
32,000342,000
Pharmaceutical Research and Manufacturers of America200,000
  • Patient Engagement
  • Value
  • Health Leadership Conference
  • Washington Representatives Retreat
  • Emerging Issues
8,000208,000
Sangamo25,000
  • Fair-Market Value Calculator

25,000
Sanofi130,000
  • Payment Models/Delivery Design
  • Health Leadership Conference
32,000162,000
Takeda Pharmaceuticals North America

32,00032,000
UCB Pharmaceuticals

32,00032,000

Other 2018 Support

 
Nonprofit Member Contributions

32,000

PCORI Engagement Award(s)

218,175

University of Maryland – Baltimore Contract(s)

70,049

People Centered Research Foundation

25000

Pharmacy Quality Alliance Contract

5000

Center for Medical Specialty Societies Contract

2400

**Key for Program Name Abbreviations
Full Name of Program/ConferenceAbbreviated Name
Patient-Journey Mapping ToolboxPatient-Journey Mapping
Building Capacity to Enhance the Patient Centricity of Patient-Reported OutcomesClinical Outcome Assessment
Patient Engagement in Medical Product DevelopmentPatient Engagement
Tools to Support Sponsor-Patient Engagement: Fair-Market Value CalculatorFair-Market Value Calculator
Payment Models and Delivery System Design to support Patient-Centered CarePayment Models/Delivery System
Patient Engagement in Evaluating the Quality of CareQuality
Patient Perspectives on the Value of TreatmentsValue
Patient Perspective on the Use of Real-World EvidenceReal-World Evidence
Emerging Issues Action Fund (formerly Policy Development Fund)Emerging Issues
Health Leadership ConferenceHealth Leadership Conference
Washington Representatives RetreatWashington Representatives Retreat
Science of Patient Engagement Symposium (formerly the Chief Scientific/Medical Officer and Research Directors Meeting)Science Symposium